QIM22-194: Using the Merlin Assay to Reduce Sentinel Lymph Node Biopsy Rates and Its Complications: A Retrospective Cohort Study
Journal of the National Comprehensive Cancer Network | March 31, 2022 | Volume: 20 | Issue: 3.5 | Pages: QIM22-194
10.6004/jnccn.2021.7223